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Abstract
Biochemical and cell-biological experiments have identified cholesterol as an important component of lipid ‘rafts’ and related structures
(e.g., caveolae) in mammalian cell membranes, and membrane cholesterol levels as a key factor in determining raft stability and organization.
Studies using cholesterol-containing bilayers as model systems have provided important insights into the roles that cholesterol plays in
determining lipid raft behavior. This review will discuss recent progress in understanding two aspects of lipid–cholesterol interactions that
are particularly relevant to understanding the formation and properties of lipid rafts. First, we will consider evidence that cholesterol interacts
differentially with different membrane lipids, associating particularly strongly with saturated, high-melting phospho- and sphingolipids and
particularly weakly with highly unsaturated lipid species. Second, we will review recent progress in reconstituting and directly observing
segregated raft-like (liquid-ordered) domains in model membranes that mimic the lipid compositions of natural membranes incorporating raft
domains.
D 2003 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cholesterol–lipid interactions have long been recognized
as an important element in membrane structure and choles-
terol homeostasis in animal cells. The nature of lipid–sterol
interactions has accordingly been intensively studied, using
a variety of physical methods (for reviews see Refs. [1–7]).
An exciting new aspect of this field has emerged with the
recognition that the plasma and other membranes of animal
cells may incorporate laterally segregated domains known
as ‘lipid rafts.’ As currently understood, rafts are considered
to comprise relatively small (submicroscopic) domains that
are depleted in unsaturated phospholipids and many (though
not all) transmembrane proteins but enriched in cholesterol,
sphingolipids and certain lipid-anchored proteins [8,9].
Rafts and related membrane microdomains such as caveolae
have been proposed to play important roles in sorting of
membrane molecules and in signal transduction in animal
cells (reviewed in Refs. [10–20]).
Two major observations suggest that cholesterol–lipid
interactions play an important role in the formation of rafts
in animal cell membranes. First, as already noted, ‘raft’
fractions isolated from mammalian cells typically are found
to be enriched in cholesterol [8,21,22]. Second, disruption
or depletion of cell membrane-associated cholesterol can
induce major changes in the distribution and/or function of
raft-associated membrane components [23–31]. Studies of
cholesterol-containing model membranes have played an
important role in elucidating the physical bases for such
findings and, more generally, in deepening our understand-
ing of how cholesterol contributes to the formation and the
organization of lipid rafts [32].
This review will discuss two types of studies of choles-
terol–lipid interactions whose findings are particularly ger-
mane to understanding the origin and organization of lipid
rafts. First, we will review the results of thermodynamic and
spectroscopic studies that support longstanding suggestions
that cholesterol interacts differentially with different mem-
brane lipids and, among naturally occurring lipids, shows a
particular affinity for sphingolipids. Further discussions of
this aspect of cholesterol–lipid interactions can be found in
the chapter by McConnell and Radhakrishnan in this issue
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[32,33]. These findings are of biological interest, not only
for their potential relevance to the formation of lipid rafts
but also in other physiological contexts, as for example in
understanding the energetics of lipid sorting and transport
between different cellular membranes. Second, we will
consider recent studies demonstrating the formation of
segregated liquid domains in model membranes combining
cholesterol with phospho- and sphingolipids, and the impor-
tant role played by cholesterol in modulating and even
promoting such domain segregation. In both cases, we will
focus on recent developments and unresolved questions in
these areas, and on how progress in these fields is contri-
buting to our understanding of the origin and properties of
cholesterol-enriched microdomains in biological mem-
branes. We begin with an overview of some of the particular
challenges that have complicated investigation of the nature
of sterol/lipid interactions.
2. Special challenges in studying cholesterol– lipid
interactions
The interactions of lipids and sterols in lipid bilayers
have been studied extensively, using a variety of spectro-
scopic and thermodynamic methods, for over 40 years. In
spite of such intensive efforts, fundamental gaps remain in
our understanding of the nature and consequences of cho-
lesterol–lipid interactions. This situation in part reflects
some distinctive features of cholesterol–lipid systems that
complicate their analysis.
Characterization of the interactions between various
phospho- and sphingolipids in lipid bilayers has been
facilitated by the broadly similar (and relatively straightfor-
ward) phase equilibria of different species and by their
tendencies to form large, coexisting domains in phase-
separated lipid mixtures (for reviews see Refs. [34–36]).
Cholesterol, by contrast, forms crystals rather than bilayers
when dispersed in aqueous media, strongly broadens the
phase transitions of phospho- and sphingolipids with which
it is intermixed and can adopt complex patterns of lateral
organization in mixtures with other lipids (reviewed in Refs.
[1–7]). Such factors greatly complicate the analysis and
modeling of the thermotropic properties of lipid–cholesterol
mixtures. While significant advances have been made in
evaluating these questions at both a theoretical and an
experimental level, at present our picture of the microscopic
organization of lipid/cholesterol bilayers is far from com-
plete.
Ipsen et al. [37,38] provided an important conceptual tool
for understanding lipid–cholesterol interactions by postu-
lating, on the basis of theoretical simulations, that choles-
terol and saturated phospholipids could form a ‘liquid-
ordered’ phase that could coexist with other lipid phases
such as the familiar ‘fluid’ (liquid-disordered) and gel
phases formed by pure phospholipids. Subsequent NMR
studies of lipid–cholesterol bilayers [39–42] provided
experimental support for this hypothesis. These studies
provided two important elements that have shaped much
subsequent thought concerning the organization of choles-
terol-containing membranes. First, in the concept of a
‘liquid-ordered’ phase, Ipsen and colleagues focussed and
extended previous conclusions that cholesterol promotes a
state of ‘intermediate fluidity’ between the familiar gel and
fluid phases formed by pure phospho- and sphingolipids
[2–7]. Specifically, these workers noted that liquid-ordered
bilayer domains could exhibit a degree of translational
freedom (crudely, lateral mobility) of the lipid molecules
that was similar to that of a conventional fluid bilayer state,
while at the same time the configurational freedom (order)
of the lipid hydrocarbon chains more closely resembled that
of the gel state. Second, the studies just described provided
evidence that the liquid-ordered state could, at least in some
circumstances, constitute a distinct phase that could coexist
with other, more conventional gel or fluid lipid phases.
These studies thereby offered theoretical support for the
possibility that liquid-ordered domains might coexist with
other lipid domains in sterol-containing biological mem-
branes. While other workers have proposed phase diagrams
for lipid/cholesterol binary mixtures that are more complex
than that originally proposed by Ipsen et al. (see for example
Ref. [43]), there is fairly broad agreement that such mixtures
can exhibit at least one phase with liquid-ordered character-
istics, and that liquid-ordered and liquid-disordered domains
can coexist in these systems.
While the idea of a ‘liquid-ordered phase’ has proven
very powerful for conceptualizing the possible nature of
‘lipid rafts’ and related domains in biological membranes, it
is important to note that the origin and the detailed structure
of the condensed phases favored by cholesterol remain to be
fully clarified, even in some very fundamental aspects.
Based on extensive monolayer studies (reviewed in Ref.
[33] in this volume), McConnell and colleagues have
proposed that cholesterol cooperatively forms condensed
molecular complexes with certain lipid species (e.g., longer-
chain saturated phospholipids), and that this phenomenon
plays an important role in promoting fluid–fluid phase
separations in biological membranes [44–46]. Other work-
ers have presented evidence that cholesterol may adopt a
regular distribution in mixtures with other lipids [47–50]
and have suggested that segregated domains, exhibiting
different lattice arrangements of sterol and lipid molecules,
may coexist in cholesterol-containing bilayers. Huang and
Feigenson [51] have shown by computer modeling that
highly regular distributions of cholesterol and lipids can in
principle arise without the formation of specific complexes
(in a chemical sense) between the lipid and sterol molecules.
A common feature of the above proposals is their emphasis
on the importance of multibody, as opposed to strictly
pairwise, interactions between lipid and sterol molecules
in determining the organization and physical properties of
lipid/cholesterol bilayers. Inclusion of such effects will
enrich, but also inevitably complicate, theoretical modeling
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of the organization of lipid–cholesterol systems, since in
principle the relevant multibody interactions can take many
different forms.
Alongside the theoretical complexities discussed above,
it is worth noting that the preparation of homogeneous
lipid–cholesterol samples can pose a significant experimen-
tal challenge in certain circumstances. Most conventional
methods of lipid-vesicle preparation, in which the lipids are
first dried down together from a solvent, entail the risk that
lipid and sterol components may dry down at different rates
as the solvent evaporates, yielding an inhomogeneous final
sample. The problem can be mitigated somewhat by judi-
cious choice of solvents and sample drying conditions [41;
D. del Giudice and J. Silvius, unpublished results] but (at
least in our experience) remains a challenge for samples
with elevated cholesterol contents ( > ca. 40 mol%). Buboltz
and Feigenson [52] have recently described a novel method,
based on rapid solvent removal in an aqueous medium, that
provides homogeneous vesicle preparations with cholesterol
contents ranging up to the apparent thermodynamic (satu-
ration) limit. It will be of great interest to compare the
physical properties of cholesterol-rich dispersions prepared
using this or related methods (e.g., rapid dilution from
ethanol [53]) to those previously reported for analogous
dispersions prepared by conventional solvent-drying/hydra-
tion protocols.
3. Experimental evidence for differential interactions of
cholesterol with different lipid species
A variety of methods has been used to examine the
physical consequences of cholesterol incorporation into
lipid bilayers [1–7]. While cholesterol produces qualita-
tively similar effects on the behavior of diverse types of
phospho- and sphingolipids (e.g., ordering and condensing
fluid-phase bilayers and ‘fluidizing’ gel-state bilayers),
more detailed comparisons reveal significant differences in
the interactions of cholesterol with different lipids. In the
following sections we will review some of the experimental
evidence for such differential interactions, particularly those
that may occur in the biologically important fluid state.
3.1. Calorimetric studies
Early indications that cholesterol interacts differently
with different lipid species were provided by results from
calorimetric experiments (for reviews see Refs. [1–7]).
Cholesterol strongly broadens the thermotropic gel-to-
liquid-crystalline phase transitions of a variety of phospho-
and sphingolipids [54,55]. However, careful analysis reveals
quantitative and even qualitative differences in the effects of
cholesterol on the phase transitions of phospholipids that
differ in their acyl chain and/or headgroup structures (see for
example Refs. [56–60]). Most dramatically, it has been
reported that the gel-to-liquid-crystalline phase transitions of
phospholipids with two polyunsaturated chains are not
significantly perturbed by even equimolar proportions of
cholesterol in the bilayer [61], while much lower bilayer
concentrations of cholesterol strongly broaden the sharp
phase transitions of saturated phospholipids [55].
Further suggestions that cholesterol may show differential
interactions with different lipid species were provided by
calorimetric studies of ternary (lipid/lipid/cholesterol) mix-
tures [62–64]. These workers noted that in mixtures of lipids
exhibiting very extensive phase separation, cholesterol in
some cases perturbed differentially the endothermic transi-
tion components associated with the different lipid species.
From systematic studies of a variety of such ternary mix-
tures, van Dijck and colleagues concluded that cholesterol
interacts with different headgroup classes of phospholipids
with different affinities, in the order sphingomyelin>phos-
phatidylserine>phosphatidylcholine>phosphatidylethanola-
mine. While these conclusions are intriguing, it is difficult to
deduce from such findings whether cholesterol interacts
differentially with different phospholipid components in a
given single phase (e.g., the fluid phase). Complicating
further the interpretation of the findings just discussed,
subsequent studies reported that the thermotropic behavior
of other lipid mixtures, combining cholesterol with phos-
pholipids with more nearly ideal miscibilities, did not
suggest preferential interactions of the sterol with one type
of lipid headgroup over another [65,66]. Nonetheless, as
discussed in the following sections, two additional techni-
ques, monolayer measurements and direct assays of choles-
terol partitioning between different bilayer environments,
have yielded results that support (at least qualitatively) the
conclusions of the calorimetric experiments discussed above.
Estimates of the maximum solubility of cholesterol in
different lipid bilayers have also suggested marked differ-
ences in the interaction of cholesterol with lipids with
different headgroups, at least at high levels of cholesterol
(for further discussion see the article by Bach and Wachtel
[67] in this volume). Huang et al. [68] found that the
maximum solubility of cholesterol in bilayers of various
saturated and monounsaturated phosphatidylcholines was
67 mol%, as compared to only 51 mol% in phosphatidyle-
thanolamine bilayers. In a subsequent theoretical analysis
[69], these workers argued that this difference in solubility
limits reflects an important difference in the nature of the
interactions of cholesterol with the two types of phospho-
lipids, dictated by the different effective sizes of the phos-
pholipid headgroups. Other studies have suggested that the
maximum solubility of cholesterol in phosphatidylserine
bilayers may be substantially lower than that in bilayers of
phosphatidylcholine or phosphatidylethanolamine with the
same acyl chains [67], although divergent findings have
been reported [58,70]. Brzustowicz et al. [71] have reported
that the maximum solubility of cholesterol in bilayers of
highly unsaturated phosphatidylcholines is substantially
lower than that in bilayers composed of saturated or mono-
unsaturated species, again suggesting that highly unsatu-
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rated lipids may exhibit particularly weak interactions with
cholesterol.
3.2. Monolayer measurements
Monolayer methods have long played an important role
in the study of cholesterol–lipid interactions, providing
among other insights the first demonstration of the ‘con-
densing effect’ that cholesterol exerts upon lipids in the fluid
state (reviewed in Refs. [1,72]). At a given surface pressure,
mixtures of cholesterol with various phospho- and sphingo-
lipids typically show average molecular areas that are
smaller than the weighted average of the molecular areas
of the lipid and sterol components. The magnitude of this
area-condensing effect (particularly at surface pressures
thought to approximate those prevailing in bilayers) has
been used as a rough indicator of the relative strength of
interaction of cholesterol with diverse phospholipid species.
Such studies have suggested for example that phospholipids
bearing two unsaturated chains show markedly weaker area
condensation than do species bearing at least one saturated
chain [73,74].
Recent work has suggested that cholesterol-induced re-
ductions in interfacial elasticity provide a more sensitive
index than do area-condensation measurements to compare
the strength of interactions between cholesterol and different
lipid species in monolayers. In a study of phosphatidylcho-
line/cholesterol monolayers spread at a surface pressure
considered to approximate that prevailing in biological mem-
branes, Smaby et al. [75] showed that the extent of the
interfacial elasticity reduction produced by cholesterol varies
strongly with the structures of the acyl chains. The magnitude
of this effect was found to be greatest for disaturated
phosphatidylcholines, substantially less for species bearing
one mono- or diunsaturated chain, still smaller for species
bearing two such chains or one polyunsaturated chain, and
very small for species bearing two polyunsaturated chains.
The results obtained from both area-condensation and elas-
ticity-reduction measurements thus suggest that highly unsa-
turated lipid species interact relatively weakly with
cholesterol. This conclusion is supported by calorimetric
results discussed earlier [61] and by fluorescence- and
NMR-based findings that cholesterol exerts relatively weak
ordering effects on highly polyunsaturated phospholipids in
bilayers [76,77]. Interfacial-elasticity measurements suggest
more generally that over a wide range of lipid acyl-chain
compositions, species with increasing saturation show pro-
gressively stronger interactions with the sterol. As discussed
later, these conclusions agree with those derived from studies
of bilayer systems using other techniques.
Several recent monolayer studies have examined the
interactions of cholesterol with different sphingolipids com-
pared to phospholipids with similar physical properties.
Initial monolayer studies based on area-condensation meas-
urements, particularly using a lateral pressure thought to
approximate that prevailing in biological membranes (30
mN/m), showed little difference in the interaction of choles-
terol with sphingomyelins (or galactosylcerebrosides in the
liquid state) compared to phosphatidylcholines with similar
hydrocarbon chains [74,78]. In other aspects, however, such
as the kinetics of cholesterol desorption or oxidation by
cholesterol oxidase, cholesterol/sphingomyelin monolayers
behave quite differently from similar monolayers incorpo-
rating chain-matched phosphatidylcholines [79–82]. In
agreement with these latter findings, recent studies [83],
measuring the elasticity-reducing rather than the area-con-
densing effect of cholesterol in monolayers, have suggested
a significantly stronger interaction of cholesterol with
sphingomyelins compared to phosphatidylcholines with
similar hydrocarbon chain lengths. Studies of cholesterol
interactions with sphingomyelin analogues in monolayers
(and lipid vesicles) have suggested that this difference is
mainly determined by the presence of an amide linkage in
sphingomyelin [84,85].
3.3. Cholesterol-partitioning measurements
Cholesterol can exchange spontaneously between differ-
ent fluid lipid vesicles much faster than do most membrane
lipids, requiring a few hours or less to redistribute to equili-
brium in some systems. By examining the equilibrium dis-
tribution of cholesterol between different lipid vesicles (or
biological membranes), it has thus been possible to compare
directly the affinities of the sterol for bilayers with different
compositions (Table 1). Using this approach, Yeagle and
Young [86] concluded that cholesterol associates with greater
affinity with unsaturated phosphatidylcholines than with
unsaturated phosphatidylethanolamines. Using a similar
approach, Lange et al. [87] showed that cholesterol partitions
with roughly twofold greater affinity into vesicles prepared
from a saturated phosphatidylcholine or sphingomyelin than
into vesicles prepared from an unsaturated (egg yolk) phos-
phatidylcholine. These studies suggested that in fluid bilayers
cholesterol interacts differentially with different membrane
lipids, with affinity varying in the order sphingomye-
lin>PC>PE, and can discriminate as well between species
with different acyl chains. Studies of cholesterol partitioning
between lipid vesicles with more complex compositions,
including mixtures of lipids extracted from biological mem-
branes, gave results entirely consistent with these conclusions
[88–90].
Most of the cholesterol-partitioning studies just described
were carried out using small unilamellar vesicles, which
allow faster equilibration of cholesterol than do larger
vesicles. We have recently shown, however, that h- or g-
cyclodextrins, acting catalytically, can strongly accelerate
intervesicle cholesterol transfer, allowing ready measure-
ment of the partitioning of cholesterol between large uni-
lamellar vesicles with widely varying compositions [91].
Such measurements showed that the affinity of cholesterol
for different phospholipids varies significantly with polar
headgroup and ‘backbone’ structure, in the order sphingo-
J.R. Silvius / Biochimica et Biophysica Acta 1610 (2003) 174–183 177
myelin>PS>PC>PE. This order of affinities agrees well with
that deduced from the earlier cholesterol-partitioning studies
described above, and strikingly, with that deduced from
calorimetric experiments as discussed earlier [62–64]. The
affinity of cholesterol for phospholipids was also found to
decrease strongly with increasing unsaturation of the lipid
acyl chains. As a result of these combined factors, choles-
terol for example associates roughly sixfold more avidly
with (largely saturated) sphingomyelin than with 1-stearoyl-
2-arachidonoyl phosphatidylcholine in fluid bilayers [91].
This result suggests that sphingolipid-enriched liquid-
ordered microdomains will be relatively enriched in choles-
terol, consistent with the compositional data reported for
detergent-insoluble ‘raft’ fractions isolated from model and
mammalian cell membranes [8,21,22].
3.4. Spectroscopic studies
As discussed earlier, 2H-NMR studies of the behavior of
bilayers combining cholesterol with saturated phosphatidyl-
cholines played an important role in shaping our current
picture of the ‘liquid-ordered’ state. These findings naturally
raised questions whether other types of phospho- and
sphingolipids can also adopt a liquid-ordered state in the
presence of cholesterol. Thewalt and Bloom [92] concluded
from 2H-NMR measurements that mixtures of cholesterol
and monounsaturated phosphatidylcholines can adopt a
liquid-ordered state, and that the overall phase diagrams
for these systems are broadly similar to those determined
earlier for mixtures of saturated phosphatidylcholines and
cholesterol [39–42], though shifted downward on the tem-
perature axis in accord with the lower transition temper-
atures of the monounsaturated lipids. Fluorescence-lifetime
measurements using trans-parinaric acid-labeled choles-
terol/POPC bilayers have also suggested the formation of
domains with liquid-ordered properties in this system [93].
In spite of this apparent qualitative similarity in the behavior
of saturated and monounsaturated phospholipids in the
presence of physiological levels of cholesterol, electron spin
resonance experiments have suggested that the lateral inter-
actions between lipid and cholesterol molecules are in fact
significantly different in the two types of lipid–sterol
mixtures [94–96]. NMR and fluorescence-spectroscopic
studies have also suggested that bilayers composed of
cholesterol and highly unsaturated phospholipids differ
sharply in their lateral organization from bilayers combining
cholesterol with more saturated lipid species [76,77].
3.5. Synthesis
The various approaches described above yield a broadly
consistent picture of the differential interactions of choles-
terol with different lipid species. First, the strength of such
interactions, as assessed by a variety of measures, gradually
decreases as the extent of lipid unsaturation increases. The
common perception that cholesterol interacts preferentially
with saturated lipid species in membranes, while technically
correct, should thus not be extended to imply that all
unsaturated lipid species behave identically in cholesterol-
containing membranes. Using a fluorescence-quenching
assay, we have found for example that monounsaturated,
but not polyunsaturated, lipid species can partition to a
significant extent into liquid-ordered domains in choles-
terol-containing bilayers [97]. A second consistent finding
from various physical studies is that the nature and affinity of
lipid–cholesterol interactions can also vary significantly with
the structure of the lipid polar headgroup and backbone. The
preferential interaction of cholesterol with ‘typical’ mem-
brane sphingolipids, compared to ‘typical’ membrane phos-
pholipids, thus reflects differences in the structures of both
the polar portions and the acyl chains of these two lipid
classes. As discussed below, these differential interactions
Table 1
Partition coefficients (Kp) for cholesterol distribution between different donor and acceptor vesicles at 37 jC
Lipid composition A Lipid composition B Kp(B/A)
a Conditionsb Reference
Egg PC Brain sphingomyelin 2.0 SUV, 46 jC [87]
Egg PC N-16:0 sphingomyelin 1.9 SUV, 46 jC [87]
Egg PC 16:0/16:0 PC 1.9 SUV, 46 jC [87]
16:0/181 PC 14:0/14:0 PC 1.8 LUV, 37 jC [86]
16:0/181 PC 16:0/18:1 PC/PE (1:1) 0.8 LUV, 37 jC [86]
16:0/181 PC 16:0/18:1 PC+ 18:1/18:1 PE (1:1) 0.6 LUV, 37 jC [86]
18:0/18:1 PC 18:2/18:2 PC 0.31 LUV, 37 jC [91]
18:0/18:1 PC 18:0/20:4 PC 0.45 LUV, 37 jC [91]
18:0/18:1 PC 18:1/18:1 PC 0.51 LUV, 37 jC [91]
18:0/18:1 PC 18:0/18:2 PC 0.66 LUV, 37 jC [91]
18:0/18:1 PC 18:0/18:1 PE + 18:0/18:1 PS (85:15) 0.67 LUV, 37 jC [91]
18:0/18:1 PC 18:0/18:1 PS 1.45 LUV, 37 jC [91]
18:0/18:1 PC 18:0/18:1 PC+ 16:0/16:0 PC (50:50) 1.67 LUV, 37 jC [91]
18:0/18:1 PC 18:0/18:1 PC+ brain sphingomyelin (50:50) 2.56 LUV, 37 jC [91]
a K(B/A) = relative preference for vesicles of composition B compared to composition A, calculated from data reported in the indicated references.
b SUV/LUV—small/large unilamellar vesicles.
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can promote formation of segregated fluid lipid domains in
bilayers combining cholesterol with sphingolipids and unsa-
turated phospholipids.
4. Evidence for lateral inhomogeneity in fluid bilayers
containing cholesterol
4.1. Detergent-fractionation and fluorescence studies
While solid/fluid phase separations were demonstrated
many years ago in lipid model membranes, the potential
formation of laterally segregated lipid domains in mamma-
lian cell membranes was long regarded as a strictly theo-
retical possibility, since gel-phase lipid domains are not
observed in most such membranes at physiological temper-
atures. Cholesterol was moreover often considered to pro-
mote homogenization of lipid properties, and hence to
suppress the tendency of lipids to form segregated domains,
in biological membranes. Evidence to modify this view was
first provided by a combination of fluorescence-microscopic
studies of lipid monolayers [98,99] and, as discussed earlier,
theoretical and NMR studies of cholesterol–phosphatidyl-
choline bilayers [37–42], which suggested that cholesterol
could promote fluid–fluid phase separations. As noted
earlier, this latter concept gained particular interest follow-
ing the isolation and characterization of membrane ‘raft’
fractions from mammalian cells [8,9].
Studies like those just noted, suggesting the possible
existence of lipid microdomains in the plasma (and possibly
other) membranes of mammalian cells, received strong
support from parallel studies of lipid vesicles constructed
to mimic the lipid component of these membranes [100].
Schroeder et al. [21] demonstrated that when mixtures of
sphingolipids, unsaturated phospholipids and cholesterol
were treated in the cold with nonionic detergents such as
Triton X-100, the lower-melting phospholipids were readily
solubilized while the higher-melting sphingolipid species,
and to a lesser extent cholesterol, were largely recovered
in an unsolubilized, sedimentable fraction. These results
strongly resembled those observed when mammalian cell
membranes were treated with the same detergents under
comparable conditions. Similar results were obtained using
analogous lipid mixtures without cholesterol, or in which
long-chain saturated phospholipids replaced the sphingolipid
component. Measurements of diphenylhexatriene fluores-
cence polarization suggested that the existence of a deter-
gent-insoluble fraction was correlated with the presence of
ordered (gel or liquid-ordered) lipid domains in the original
bilayers.
Direct evidence that cholesterol can promote, rather than
simply support, the formation of segregated domains in fluid
lipid bilayers was first obtained using fluorescence-quench-
ing assays [32,97,101–104]. These assays demonstrated
first, that at physiological temperatures mixtures combining
cholesterol, unsaturated phospholipids and saturated phos-
pho- or sphingolipids form laterally segregated domains
and, second, that cholesterol can actually induce such
domain segregation in bilayers containing relatively low
levels of saturated lipids. Related fluorescence-quenching
measurements have demonstrated that in such systems
saturated phospholipids and sphingolipids, as well as pep-
tides modified with multiple saturated acyl chains, partition
with substantial affinities into domains enriched in the
saturated lipid species. By contrast, multiply unsaturated
species show essentially no affinity for such domains under
the same conditions [97,105,106]. These findings provide
direct support for previous hypotheses concerning the phys-
ical bases of ‘raft’ association of various membrane lipids
and lipid-modified proteins [12,13,15,21]. Interestingly,
however, mixtures combining physiological levels of cho-
lesterol with lipids resembling those found at the inner
surface of the plasma membrane do not appear to form
coexisting lipid domains [107].
4.2. Microscopic studies
The fluorescence-quenching studies just noted provide
direct evidence for the formation of laterally segregated
domains in lipid bilayers with compositions mimicking that
of the plasma membrane. However, fluorescence-quenching
methods can in principle detect the segregation of even very
small lipid domains, with dimensions as small as several
nanometers or tens of nanometers [108]. Fluorescence and
atomic force microscopy have recently been used in an
effort to assess more directly the dimensions and morphol-
ogies of coexisting segregated domains in cholesterol-con-
taining mono- and bilayers.
For technical reasons, epifluorescence microscopy was
first used to examine monolayers combining cholesterol
with phospho- or sphingolipids. These studies revealed that
cholesterol-containing monolayers could exhibit segregated
liquid-phase domains with micron dimensions under certain
conditions of composition, temperature and surface pressure
[44–46,98,99,109–114]. Such monolayers, however, typi-
cally show increasing intermingling (and a reduction in the
average dimension) of the coexisting domains, and ulti-
mately formation of a visually homogeneous phase, as the
surface pressure increases toward a threshold value deter-
mined by the lipid composition [44,114,98]. For many
monolayer compositions the threshold surface pressure falls
below the values thought to prevail in bilayer membranes
(30–35 mN/m), and it is thus unclear whether segregation
of large domains would occur in bilayers with such com-
positions. Significantly, however, coexisting micron-sized
liquid domains have been observed even at ‘physiological’
surface pressures in monolayers prepared from mixtures of
unsaturated phospholipids, sphingomyelin and cholesterol
[46]. Monolayer studies thus demonstrate, first, that choles-
terol-containing systems can form large (micron-dimension)
coexisting liquid domains under certain conditions (includ-
ing, potentially, physiological conditions) and, second, that
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the size, the morphology and even the existence of such
domains can vary strongly in response to modest changes in
variables such as composition or temperature.
Several recent microscopic studies have extended the
conclusions just noted from mono- to bilayer systems [115–
118]. These studies have demonstrated that mixtures of
unsaturated phosphatidylcholine, sphingolipids and choles-
terol, in supported bilayers, giant unilamellar vesicles or
black lipid membranes, can exhibit coexistence of micron-
sized segregated liquid domains. Qualitatively similar
domains are observed in ternary mixtures in which the
sphingolipid component is replaced by a long-chain satu-
rated phospholipid, or using a lipid mixture extracted from
renal epithelial brush-border membranes [115,117]. Atomic
force microscopy (AFM) has provided a similar picture of
the organization of mica-supported bilayers spread from
sphingomyelin/unsaturated phospholipid/cholesterol mix-
tures at ‘physiological’ surface pressures (30–32 mN/m
[119,120]). The coexisting domains in these systems appear
fluid and dynamic, as indicated by their smooth, rounded
borders and their ability to coalesce rapidly after contact
[117]. Interestingly, fluorescence microscopy and AFM both
indicate that low-temperature Triton X-100 extraction of
supported bilayers selectively removes regions of the bilayer
identified as liquid-disordered, while leaving essentially
intact those identified as liquid-ordered [115,119,120].
Additional findings support the conclusion that the
coexisting domains observed in cholesterol/unsaturated
phospholipid/sphingolipid bilayers provide a useful, if ap-
proximate, model for ‘raft’ vs. ‘non-raft’ domains in mam-
malian cell membranes. First, the domains identified as
liquid-ordered in the lipid model systems preferentially
accumulate ganglioside GM1 and the glycosylphosphatidy-
linositol-anchored (GPI-) protein Thy-1, both of which also
associate with ‘lipid rafts’ in mammalian cells [115,117].
Second, antibody-mediated cross-linking of a saturated lipid
probe, which as a monomer shows only a modest affinity for
liquid-ordered domains, enhances partitioning into liquid-
ordered domains by severalfold, consistent with findings
that cross-linking markedly enhances association of certain
membrane components with ‘raft’ fractions in mammalian
cells [116]. Finally, and rather curiously, incorporation of as
little as 1 mol% GM1 into the model lipid bilayers sub-
stantially reduced the partitioning of the GPI-anchored Thy-
1 into liquid-ordered domains [116]. A similar reduction of
GPI–protein partitioning into ‘raft’ domains was reported
after incorporation of exogeneous gangliosides into the
plasma membrane of mammalian cells [121]. The origin
of this intriguing effect remains unknown, although other
studies also raise the possibility that gangliosides, even
at low concentrations, may exhibit rather complex behav-
ior in membranes incorporating liquid-ordered domains
[122,123].
The results of the above and other studies indicate that
cholesterol can modulate the organization of bilayers com-
bining saturated and unsaturated lipids in at least three ways.
First, of course, as already discussed, in bilayers that exhibit
coexisting (solid/fluid) domains even in the absence of
cholesterol, the addition of cholesterol can transform
solid-phase domains into liquid-ordered domains. Second,
and also as discussed earlier, in some cases cholesterol can
induce or enhance the formation of segregated domains
under conditions where such segregation does not occur in
the absence of sterol (see for example Ref. [116]). Finally,
the presence of cholesterol can alter markedly the dimen-
sions and morphology of segregated domains in lipid
bilayers. Perhaps most interesting in this regard are obser-
vations suggesting that under certain conditions, cholesterol
may promote the formation of very small domains that
cannot be observed by microscopy but whose presence
can be detected by fluorescence-quenching approaches.
Dietrich et al. [115] thus observed, for example, that in
giant cholesterol/sphingomyelin/dioleoyl phosphatidylcho-
line vesicles no microscopically visible segregated domains
were present above ca. 26 jC. By contrast, fluorescence-
quenching measurements, which monitor lipid lateral dis-
tributions on much smaller distance scales (nm), indicate
that bilayers with such compositions continue to exhibit
domain segregation even at physiological temperatures
[102]. Similar evidence for the formation of segregated
liquid domains smaller than the optical resolution limit
has been obtained in other systems incorporating physio-
logical proportions of cholesterol (compare for example
Refs. [101] and [124]). Varma and Mayor [124] have
proposed that under some conditions, such lipid mixtures
may not undergo true phase separation but rather exhibit a
‘nanocomposite’ organization, with more and less ordered
domains intimately intermingled on a submicron scale of
distances. These findings are of interest in the light of
observations that in unperturbed mammalian cell mem-
branes, ‘lipid rafts’ are submicroscopic domains [125,126]
and may have dimensions as small as a few tens of nano-
meters [126]. Interestingly, depletion of cholesterol from the
plasma membranes of CHO cells has been reported to
increase the size of segregated lipid domains to micron
dimensions [127].
Results obtained using both fluorescence and atomic
force microscopy indicate that the segregated domains in
sphingolipid/unsaturated phospholipid/cholesterol bilayers
are aligned between the two leaflets of the bilayer
[115,117,119,120], as has been demonstrated previously
for cholesterol-free bilayers exhibiting gel/liquid-crystalline
phase separation [128]. It is thus clear that in fluid, choles-
terol-containing lipid bilayers, correlation of physical prop-
erties between the two bilayer leaflets is possible. This
finding is noteworthy in view of the apparent transmem-
brane character of ‘rafts’ in biological membranes, as
evidenced for example by correlations in the distributions
of ‘raft’ markers between the inner and outer leaflets of the
plasma membrane in some systems [129–132]. However,
since the cytoplasmic and extracytoplasmic leaflets of the
plasma membrane differ greatly in composition [133,134], it
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is not yet clear whether the physical factors that promote
alignment of liquid-ordered domains in symmetrical model
membranes are the same as those that confer a transmem-
brane character to ‘rafts’ in biological membranes.
4.3. Synthesis
Observations that cholesterol can actually enhance, rather
than merely support, the tendency of saturated phospho- and
sphingolipids to segregate from unsaturated phospholipids in
bilayer membranes are consistent with findings discussed in
earlier sections that cholesterol interacts with greater affinity
with saturated membrane lipids. Observations that in some
cholesterol-containing bilayers segregated domains of sub-
microscopic dimensions may be present, and that the posi-
tions of liquid-ordered domains can be correlated between
the two bilayer leaflets, have evident potential implications
for understanding the organization of ‘lipid rafts’ in mam-
malian cell membranes.
Results from studies of model membranes also raise, but
do not resolve, intriguing questions concerning other key
aspects of raft organization. The classic image of a lipid raft
is a small, closed patch of liquid-ordered lipids surrounded
by a continuous liquid-disordered phase. The results of
studies of cholesterol-containing model systems, however,
suggest other possible geometries for lipid rafts under certain
conditions, ranging from large domains to an extended
(stripe) or reticular arrangement of domains to a ‘nano-
composite’ organization of very small, intimately inter-
mingled liquid-ordered and liquid-disordered domains
[76,115,117,124,135]. It is an open question which of these
alternatives may provide the most appropriate description of
raft organization in a given cell membrane. Similarly, to date,
little is known to define to what degree the geometries and
sizes of rafts may be dictated (and regulated) by factors such
as membrane proteins [135,136] or whether changes in these
aspects of raft organization play important roles (physiolog-
ically or pathologically) in cellular function. In the latter
regard, however, the examples of T-lymphocyte and mast
cell activation suggest that changes in at least the distribution
of raft domains on the cell surface may play important roles
in cellular signaling [130,137,138].
5. Future directions
Studies of lipid model systems continue to shape our
understanding of the physical principles governing the
formation and organization of lipid rafts, and of the key
role played by cholesterol in determining raft organization
and behavior. Recent successes in applying microscopic
approaches to study cholesterol-containing model systems
underscore the potential of such systems to provide further
important insights into the origins and properties of lipid
rafts in biological membranes. Increasingly sophisticated
model systems, for example incorporating membrane pro-
teins [139,140], or ‘asymmetric’ bilayers whose two leaflets
differ in their lipid composition will allow us to better assess
how these important features of biological membrane organ-
ization can influence the formation of raft structures. Studies
of the dynamics and stability of segregated lipid domains in
cholesterol-containing bilayers [115,117] will continue to
provide useful information to understand the analogous
properties of rafts and raft-associated molecules in intact
cell membranes [141]. Finally, novel microscopic methods
such as near-field scanning microscopy [142] and atomic
force microscopy [118–120] may allow us to investigate
directly the sizes, the morphologies and even the existence
of lipid domains whose dimensions fall below the normal
resolution limits of optical microscopy.
Much work remains to define fully the organization and
dynamics of raft domains in biological membranes. Model
system studies like those just noted promise to continue to
provide important insights and novel approaches toward this
objective.
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